Genome engineering in Bacillus anthracis using tyrosine site-specific recombinases.

Andrei P Pomerantsev1, Rita M McCall1, Margaret Chahoud1

  • 1Microbial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos One
|August 23, 2017
PubMed
Summary

Three tyrosine site-specific recombinase (T-SSR) systems enable genetic engineering in Bacillus anthracis. These tools facilitate creating strains for vaccine production and studying virulence gene regulation.